- Report
- April 2024
- 196 Pages
Global
From €5264EUR$5,450USD£4,504GBP
- Report
- March 2024
- 145 Pages
Global
From €3766EUR$3,899USD£3,223GBP
- Report
- February 2022
- 157 Pages
Global
From €2656EUR$2,750USD£2,273GBP
€5312EUR$5,500USD£4,546GBP
- Report
- January 2022
- 194 Pages
Global
From €3076EUR$3,185USD£2,632GBP
€4394EUR$4,550USD£3,761GBP
- Report
- June 2023
- 108 Pages
Global
From €3500EUR$3,882USD£3,100GBP
Circulating Tumor Cell (CTC) Diagnostics is a type of diagnostic test used to detect and monitor cancer. CTCs are cells that have broken away from a tumor and are present in the bloodstream. CTC Diagnostics is used to detect the presence of cancer cells in the blood, as well as to monitor the progression of the disease. It can also be used to assess the effectiveness of treatments. CTC Diagnostics is a relatively new technology, and is becoming increasingly important in the diagnosis and management of cancer.
CTC Diagnostics is used in combination with other diagnostic tests, such as imaging and biopsy, to provide a more comprehensive picture of the disease. It is also used to monitor the progression of the disease and to assess the effectiveness of treatments.
Some companies in the CTC Diagnostics market include Menarini Silicon Biosystems, Biocept, and Clearbridge BioMedics. Show Less Read more
